NCT05793697

Brief Summary

evaluate the value of different scores in predicting hospital mortality and Need for MV In patients presented to ED with AECOPD.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
139

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 31, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 3, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2024

Completed
Last Updated

March 31, 2023

Status Verified

March 1, 2023

Enrollment Period

8 months

First QC Date

November 23, 2022

Last Update Submit

March 30, 2023

Conditions

Chronic Obstructive Pulmonary Disease

Outcome Measures

Primary Outcomes (1)

  • Evaluate the value of different scores in predicting hospital mortality

    Assessment Of Different Scores In Predicting Outcome In Acute Exacerbation Of Chronic Obstructive Pulmonary Disease Patients In Emergency Department as DECAF(dyspnea grade V according to eMRCD,esinopenia\<0.05x10\*9/L,consolidation,acidemia\<7.30,atrial fibrillation) 1=mild,2\_3=moderate,4\_5=severe can be used to predict AECOPD-associated mortality in ED given the simple structure and data availability.

    one year

Secondary Outcomes (1)

  • Value of these scores in predicting need for MV.

    one year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patient presented to ED with acute exacerbation of COPD no gender discrimination from 18 years to unlimit age

You may qualify if:

  • All patient presented to ED with acute exacerbation of COPD.

You may not qualify if:

  • Patient presented with acute insult affecting other system.
  • Patient transferred to other centers.
  • Inadequate data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Redfern OC, Smith GB, Prytherch DR, Meredith P, Inada-Kim M, Schmidt PE. A Comparison of the Quick Sequential (Sepsis-Related) Organ Failure Assessment Score and the National Early Warning Score in Non-ICU Patients With/Without Infection. Crit Care Med. 2018 Dec;46(12):1923-1933. doi: 10.1097/CCM.0000000000003359.

    PMID: 30130262BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • reham mo abdelmonem, MD

    Assiut Uneversity

    STUDY DIRECTOR

Central Study Contacts

mohamed mo saleh, bachelor

CONTACT

01128534859drmohamed33333@gmail.com

maha mo sayed, MD

CONTACT

01009656205mahaelkholy@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 23, 2022

First Posted

March 31, 2023

Study Start

May 3, 2023

Primary Completion

January 3, 2024

Study Completion

December 3, 2024

Last Updated

March 31, 2023

Record last verified: 2023-03